Back to results
US 11,447,558 B2Granted
Bispecific antigen binding molecules comprising anti-4-1BB clone 20H4.9
AssigneeHoffmann-La Roche Inc.
InventorsClaudia Ferrara Koller, Christina Claus, Christian Klein, Pablo Umaña, Wei Xu
Life of this patent
Estimating the term…
Abstract
The invention relates to new bispecific antigen binding molecules, comprising at least one antigen binding domain capable of specific binding to 4-1BB, at least one moiety capable of specific binding to a target cell antigen, and a Fc domain composed of a first and a second subunit capable of stable association, and to methods of producing these molecules and to methods of using the same.
Claims22
A bispecific antigen binding molecule, comprising:
- two or four antigen binding domains that are Fab fragments each capable of specific binding to 4-1BB;
- an IgG Fc domain composed of a first and a second subunit capable of stable association;
- a VH and VL domain capable of specific binding to Fibroblast Activation Protein (FAP), wherein the VH domain is connected via a peptide linker to the C-terminus of one of the two first and second subunits and wherein the VL domain is connected via a peptide linker to the C-terminus of the other of the first and second subunits;
- and
- wherein the two or four antigen binding domains capable of specific binding to 4-1BB comprise two heavy chain and two light chain variable regions, or four heavy chain and four light chain variable regions, respectively, wherein:
- (i) the heavy chain variable region (VH4-1BB) comprises:
- (i) CDR-H1 comprising the amino acid sequence of SEQ ID NO:1, (ii) CDR-H2 comprising the amino acid sequence of SEQ ID NO:2, and (iii) CDR-H3 comprising the amino acid sequence of SEQ ID NO:3, and
- (ii) the light chain variable region (VL4-1BB) comprises (iv) CDR-L1 comprising the amino acid sequence of SEQ ID NO:4, (v) CDR-L2 comprising the amino acid sequence of SEQ ID NO:5, and (vi) CDR-L3 comprising the amino acid sequence of SEQ ID NO:6.
5 more elements
Dependencies are inferred from the claim text.